Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07782905

Talk2gether Program for Social Connection in Older Adults

The purpose of this study is to see if it is feasible to recruit and retain older adults in a, weekly phone call program delivered through the Harris County Precinct 2 Healthcare and Social Services Team and to see how participation in the program affect older adults' loneliness, social isolation, psychological well-being, and satisfaction, and what barriers or challenges arise during implementation

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Social Isolation or Loneliness Behavior Personal Satisfaction Psychological Well-Being Social Behavior Social Isolation

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • able to provide informed consent
  • able to speaks English or Spanish
  • able to hear sufficiently using the telephone

Exclusion criteria

  • Need for another person to consent on the participant's behalf
  • suspected or confirmed decision-making capacity impairments
  • uncontrolled psychiatric illnesses such as schizophrenia, paranoia, delusion, or delirium

Treatment and study plan

Talk2gether program

Behavioral

Participants will be paired with a trained team member. The team member will then initiate contact with the older adult(s) to begin 90 days of weekly social calls. These weekly social calls will be mostly unstructured, but supported by resource and conversation guides. At the end of 90 days, if the older adult wishes to continue to receive calls, that request will be accommodated

Primary outcomes

  1. Program Feasibility as assessed by number of participants recruited

    Time frame: end of intervention (90 days after baseline)

  2. Program Feasibility as assessed by number of participants that adhered to the weekly calls

    Time frame: end of intervention (90 days after baseline)

  3. Feasibility as assessed by number of participants that completed the program

    Time frame: end of intervention (90 days after baseline)

  4. Feasibility as assessed by number of participants that encountered barriers or challenges as assessed by the Client Satisfaction Questionnaire (CSQ-8)

    Time frame: end of intervention (90 days after baseline)

    This is an 8 item questionnaire and Items 2, 4, 5, and 8 are reverse scored. Total scores range from 8 to 32, with the higher number indicating greater satisfaction

  5. Feasibility as assessed by number of participants that encountered barriers or challenges as reported on the Caller and Older Adult feedback form

    Time frame: end of intervention (90 days after baseline)

Secondary outcomes

  1. Change in social connectedness as assessed by the Lubben Social Network Scale-6

    Time frame: baseline, post-intervention (Day 90)

    This is a 6-item self-report measure assessing perceived social support and social network size from family and friends. Each item is scored from 0 to 5, and total scores range from 0 to 30. Higher scores indicate greater social connectedness and lower risk of social isolation

  2. Change in loneliness as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) Social Isolation scale

    Time frame: Baseline, end of intervention (90 days)

    This is an 8 item scale. Each item is rated on a 5-point scale from 1(never) to 5 ( always). Raw scores range from 8 to 40 and are converted to PROMIS T-scores, with a mean of 50 and standard deviation of 10 in the reference population. Higher scores indicate greater perceived social isolation/loneliness.

  3. Change in depressive symptoms as assessed by the Patient Health Questionnaire-2

    Time frame: Baseline, end of intervention (90 days)

    This is a 2-item self-report measure . Each item is scored from 0 (not at all) to 3 (nearly every day). Total scores range from 0 to 6, with higher scores indicating greater depressive symptom burden.

  4. Change in signs of elder mistreatment as assessed by the Elder Mistreatment Screening and Response Tool (EM-SART).

    Time frame: Baseline, end of intervention (90 days)

    This is a 3 item questionnaire and each will be scored as either 1(yes) or 0(no) for a maximum score of 3. Higher scores or more endorsed concerns indicate a greater number of signs suggestive of elder mistreatment

  5. Change in sense of purpose using the 7-item Ryff Purpose in Life Scale.

    Time frame: Baseline, end of intervention (90 days)

    This is a 7 item questionnaire and each item is rated on a Likert-type scale, commonly from 1(strongly disagree) to 6( strongly agree). Negatively worded items are reverse scored, and item scores are summed to generate a total score. Total scores range from 7 to 42, with higher scores indicating a greater sense of purpose in life.

  6. Client satisfaction as assessed by the Client Satisfaction Questionnaire

    Time frame: end of intervention (90 days)

    This is an 8 item questionnaire. Scores are summed across items once. Items 2, 4, 5, and 8 are reverse scored. Total scores range from 8 to 32, with the higher number indicating greater satisfaction

Study contacts

Contact information is provided by the study sponsor or research team.

Jason Burnett, PhD

CONTACT

[email protected]

(713) 873-4685

Jordan Broussard

CONTACT

[email protected]

713 500 0321

Sponsors and collaborators

Lead sponsor

The University of Texas Health Science Center, Houston

Other

Registry information

Official study title

Talk2gether Program

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Aug 24, 2026
Registry last updated
Aug 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.